来自官方财务报表的收入、利润与现金流历史。
Nordson Corporation 设计、制造和销售用于分配、涂抹和控制粘合剂、涂料、聚合物、密封剂、生物材料、医疗组件和其他流体的产品和系统。工业精密解决方案部门为一次性产品和卷材的粘合剂、乳液、液体和纤维提供点胶、涂层和层压系统；自动粘合剂分配系统；用于热塑性塑料和生物聚合物熔体流的组件和系统；流体部件，例如喷嘴、泵和过滤器；测量和控制所分配流体的流量、数量和位置的智能组件；控制系统；和产品组装解决方案。它还提供用于冷材料、容器涂层、液体涂饰和粉末涂层的自动和手动点胶产品和系统，以及紫外线设备。医疗和流体解决方案部门提供精密手动和半自动分配器、塑料模制注射器、药筒、吸头和流体连接组件；用于工程轴和介入输送系统、医用管材、球囊、球囊充气机、镍钛诺装置、心血管插管和生物材料输送的介入解决方案；医用液体成分；和微麻痹心肌保护装置及相关耗材。先进技术解决方案部门提供自动点胶系统，用于高速、精确地应用各种附着、保护和涂层流体，以及相关的气体等离子体处理系统；破坏性和非破坏性测试技术，例如半导体和印刷电路板行业中使用的粘合测试仪以及自动光学、声学显微镜和 X 射线检测系统；及精密测控技术
机器翻译
| 利润表 | TTM → 2026-07-31 | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 | 2018-10-31 | 2017-10-31 | 2016-10-31 | 2015-10-31 | 2014-10-31 | 2013-10-31 | 2012-10-31 | 2011-10-31 | 2010-10-31 | 2009-10-31 | 2008-10-31 | 2007-10-31 | 2006-10-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | $3.0B | $2.8B | $2.7B | $2.6B | $2.6B | $2.4B | $2.1B | $2.2B | $2.3B | $2.1B | $1.8B | $1.7B | $1.7B | $1.5B | $1.4B | $1.2B | $1.0B | $819M | $1.1B | $994M | $892M |
| 毛利 | $1.6B | $1.5B | $1.5B | $1.4B | $1.4B | $1.3B | $1.1B | $1.2B | $1.2B | $1.1B | $993M | $914M | $945M | $866M | $823M | $748M | $622M | $469M | $630M | $554M | $512M |
| 毛利率% | 55.3% | 55.2% | 55.2% | 54.2% | 55.1% | 56.0% | 53.3% | 54.3% | 54.8% | 55.1% | 54.9% | 54.1% | 55.5% | 56.1% | 58.4% | 60.7% | 59.7% | 57.2% | 56.0% | 55.7% | 57.4% |
| 营业利润（EBIT） | $801M | $724M | $674M | $673M | $702M | $615M | $350M | $483M | $503M | $466M | $388M | $318M | $367M | $324M | $335M | $316M | $235M | ($128M) | $190M | $152M | $148M |
| 营业利润率% | 26.9% | 25.9% | 25.1% | 25.6% | 27.1% | 26.0% | 16.5% | 22.0% | 22.3% | 22.6% | 21.5% | 18.8% | 21.5% | 21.0% | 23.8% | 25.6% | 22.6% | -15.6% | 16.9% | 15.3% | 16.5% |
| 净利 | $555M | $484M | $467M | $487M | $513M | $454M | $250M | $337M | $377M | $296M | $272M | $211M | $247M | $222M | $225M | $222M | $168M | ($160M) | $118M | $91M | $91M |
| 净利润率 % | 18.6% | 17.3% | 17.4% | 18.6% | 19.8% | 19.2% | 11.8% | 15.4% | 16.7% | 14.3% | 15.0% | 12.5% | 14.5% | 14.4% | 16.0% | 18.0% | 16.1% | -19.5% | 10.4% | 9.1% | 10.2% |
| EBITDA | $947M | $849M | $811M | $787M | $772M | $704M | $447M | $588M | $607M | $548M | $460M | $384M | $427M | $380M | $376M | $344M | $264M | ($88M) | $229M | $185M | $177M |
| 每股收益（EPS） | $9.88 | $8.51 | $8.11 | $8.46 | $8.81 | $7.74 | $4.27 | $5.79 | $6.40 | $5.08 | $4.73 | $3.45 | $3.84 | $3.42 | $3.45 | $3.31 | $2.46 | $-2.38 | $1.71 | $1.33 | $1.33 |
| 已发行股数 (M) | 56M | 57M | 58M | 58M | 58M | 59M | 58M | 58M | 59M | 58M | 58M | 61M | 64M | 65M | 65M | 67M | 68M | 67M | 69M | 68M | 68M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 NDSN 交互式查看器。 /companies/us/NDSN
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms